Abstract
Protection of the thiol function of L,L-EC by S-thiomethylation allowed automatic deprotection during 99mTc – chelation without the use of any additional reagents. After radiolabeling (either at pH 8.5 or > 8.5), this precursor of L,L- EC produced the desired chelate that was compared to 99mTc L,L-EC, the standard chelate, by HPLC, biodistribution and scintigraphic studies. This led to the development of a single vial kit for 99mTc L,L-EC. The chromatographic and biological properties of this kit were comparable to those of the commercially available EC kits, e.g. TCK-43 and TC-IK-25. This method of chelation from S-thiomethylated precursor has been extended to prepare the corresponding technetium-99 and rhenium chelates. These chelates of the protected ligands were chromatographically (HPLC) and spectroscopically comparable to the corresponding Tc and Re chelates obtained from the unprotected precursor. The results suggest that 99mTc L,L-EC could be prepared from S-thiomethyl EC at pH 8.5 or higher, and this method of chelation could be used for the development of single vial EC kit.
Keywords: L,L'-ethylene dicysteine, S-thiomethylation, 99mTc-L,L'-EC, single vial kit
Current Radiopharmaceuticals
Title: Single Vial Kit Formulation of Technetium-99m-L,L -Ethylene Dicysteine: Its Characterisation, Biodistribution and Comparison with Commercially Available 99mTc-L, L-EC Kits
Volume: 2 Issue: 1
Author(s): Kasturi Bhattacharya, Mita Chatterjee Debnath, Kamal Krishna Halder, Sankha Chattopadhyay, Malay Kanti Das, Bharat R. Sarkar, Shantanu Ganguly and Somenath Banerjee
Affiliation:
Keywords: L,L'-ethylene dicysteine, S-thiomethylation, 99mTc-L,L'-EC, single vial kit
Abstract: Protection of the thiol function of L,L-EC by S-thiomethylation allowed automatic deprotection during 99mTc – chelation without the use of any additional reagents. After radiolabeling (either at pH 8.5 or > 8.5), this precursor of L,L- EC produced the desired chelate that was compared to 99mTc L,L-EC, the standard chelate, by HPLC, biodistribution and scintigraphic studies. This led to the development of a single vial kit for 99mTc L,L-EC. The chromatographic and biological properties of this kit were comparable to those of the commercially available EC kits, e.g. TCK-43 and TC-IK-25. This method of chelation from S-thiomethylated precursor has been extended to prepare the corresponding technetium-99 and rhenium chelates. These chelates of the protected ligands were chromatographically (HPLC) and spectroscopically comparable to the corresponding Tc and Re chelates obtained from the unprotected precursor. The results suggest that 99mTc L,L-EC could be prepared from S-thiomethyl EC at pH 8.5 or higher, and this method of chelation could be used for the development of single vial EC kit.
Export Options
About this article
Cite this article as:
Bhattacharya Kasturi, Debnath Chatterjee Mita, Halder Krishna Kamal, Chattopadhyay Sankha, Das Kanti Malay, Sarkar R. Bharat, Ganguly Shantanu and Banerjee Somenath, Single Vial Kit Formulation of Technetium-99m-L,L -Ethylene Dicysteine: Its Characterisation, Biodistribution and Comparison with Commercially Available 99mTc-L, L-EC Kits, Current Radiopharmaceuticals 2009; 2 (1) . https://dx.doi.org/10.2174/1874471010902010032
DOI https://dx.doi.org/10.2174/1874471010902010032 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis of Some Benzothiazole Based Piperazine-Dithiocarbamate Derivatives and Evaluation of Their Anticancer Activities
Letters in Drug Design & Discovery Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Current Pharmaceutical Biotechnology Bacterial Protein Microarrays for Diagnosis of Infectious Diseases
Current Immunology Reviews (Discontinued) Tropical Ginger Extract as Protectant in Radiation Countermeasures
Current Traditional Medicine Discovery and Evaluation of Efficient Selenazoles with High Antifungal Activity Against Candida spp.
Medicinal Chemistry Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Wnt/β-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme
Current Molecular Pharmacology Metabolic Activation of Herbal and Dietary Constituents and Its Clinical and Toxicological Implications: An Update
Current Drug Metabolism Synthesis and Characterization of Poly([1,2,4]triazolyl- and [1,2,4]triazolo[3,4- b][1,3,4]thiadiazinylsulfanylmethyl)arenes: Novel Multi-Armed Molecules.
Current Organic Synthesis Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
Current Drug Targets Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt
Medicinal Chemistry A Review on Chemical Structures and Biological Activities of Dopamine Derivatives from Medicinal Insects
Mini-Reviews in Medicinal Chemistry Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry Genipin Inhibits the Induction of Inducible Nitric Oxide Synthase Through the Inhibition of NF-κB Activation in Rat Hepatocytes
Drug Metabolism Letters Liposomes: A Review of Manufacturing Techniques and Targeting Strategies
Current Nanoscience Synthesis and Evaluation of Antioxidant and Cytotoxicity of the N-Mannich Base of Berberine Bearing Benzothiazole Moieties
Anti-Cancer Agents in Medicinal Chemistry Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer’s Disease Patients: How to Measure and Use It
Current Alzheimer Research Advances in Anti-inflammatory Activity, Mechanism and Therapeutic Application of Ursolic Acid
Mini-Reviews in Medicinal Chemistry Biomarker Discovery in Clinical Proteomics: Strategies for Exposing Low Abundant Proteins
Current Proteomics The Role of Neuroendocrine Cells in Prostate Cancer: A Comprehensive Review of Current Literature and Subsequent Rationale to Broaden and Integrate Current Treatment Modalities
Current Medicinal Chemistry